Anzeige
Mehr »
Login
Mittwoch, 29.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Energiekrise als Chance: Mit dieser Aktie starten Sie ins Börsenjahr 2025 durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
209 Leser
Artikel bewerten:
(1)

Tracy Taszarek Named New Executive Director of the Healthcare Plastics Recycling Council

Finanznachrichten News

NORTHAMPTON, MA / ACCESS Newswire / January 27, 2025 / The Healthcare Plastics Recycling Council (HPRC) is pleased to announce the appointment of Tracy Taszarek as its new Executive Director. Tracy succeeds Peylina Chu, who is retiring from Antea Group after a distinguished career.

Peylina has been an integral leader of HPRC since its early days in 2010. Under her leadership, the organization has grown from a group of seven members to more than 30, successfully bringing together stakeholders from across the healthcare plastics value chain. Peylina's unique ability to unite competitors and partners has driven significant progress toward a circular economy for healthcare plastics.

In addition to her leadership of HPRC, Peylina has had a distinguished career at Antea Group, a global environmental, health, safety, and sustainability consulting firm. With over 25 years of experience, she has made a lasting impact on the business community, advancing efforts in climate change, occupational health and safety, and resource management. She played a pivotal role in Antea Group's growth and success, culminating in her position as Senior Vice President.

"It has been an honor and a pleasure to work with and learn from so many HPRC members over the past 14 years. I am so proud of the work that has been completed to date, and I'm excited to see how this group continues to drive change in the industry," shared Peylina. "I look forward to the great achievements that are yet to come under Tracy's leadership!"

We are excited to welcome Tracy Taszarek to the role of Executive Director. Tracy brings over 10 years of experience managing Environmental Health and Safety (EHS) programs for diverse teams in office, manufacturing, and field-based environments. Her background in medical equipment manufacturing gives her valuable insight into the healthcare industry, which has been instrumental in her contributions to HPRC.

Tracy has been a trusted member of the HPRC team, leading projects, speaking at industry events, and facilitating council meetings. We are confident that Tracy's leadership will continue to advance HPRC's mission and expand the influence of our work within the healthcare plastics sector.

"I am very excited to step into the role of Executive Director for this incredible organization!" shared Tracy. "I'm eager to continue building strong partnerships across the healthcare plastics recycling industry and look forward to working with HPRC members to continue to drive impactful improvements."

HPRC is currently engaged in multiple initiatives aimed at enabling the recycling and circularity of healthcare plastics, including research into advanced recycling technologies to recycle mixed-stream healthcare plastics; a study of sorting technologies and potential integration with healthcare plastics waste streams; development of streamlined sustainability procurement criteria for plastic medical packaging and devices; and design of a regional recycling pilot program in the Houston market intended to serve as a blueprint for other regions.

View additional multimedia and more ESG storytelling from Healthcare Plastics Recycling Council on 3blmedia.com.

Contact Info:
Spokesperson: Healthcare Plastics Recycling Council
Website: https://www.3blmedia.com/profiles/healthcare-plastics-recycling-council
Email: info@3blmedia.com

SOURCE: Healthcare Plastics Recycling Council



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.